These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 36842195)

  • 1. Long COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factors.
    Brunner-Ziegler S; Bäuerle M; Brühl P; Kornek G; Parschalk B; Savic R; Schnetzinger M; Spath T; Straßl RP; Handisurya A; Thalhammer F
    J Infect Public Health; 2023 Apr; 16(4):596-602. PubMed ID: 36842195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The other COVID-19 survivors: Timing, duration, and health impact of post-acute sequelae of SARS-CoV-2 infection.
    Lambert N; ; El-Azab SA; Ramrakhiani NS; Barisano A; Yu L; Taylor K; Esperança Á; Mendiola C; Downs CA; Abrahim HL; Hughes T; Rahmani AM; Borelli JL; Chakraborty R; Pinto MD
    J Clin Nurs; 2024 Jan; 33(1):76-88. PubMed ID: 36181315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.
    Richard SA; Pollett SD; Fries AC; Berjohn CM; Maves RC; Lalani T; Smith AG; Mody RM; Ganesan A; Colombo RE; Lindholm DA; Morris MJ; Huprikar N; Colombo CJ; Madar C; Jones M; Larson DT; Bazan SE; Mende K; Saunders D; Livezey J; Lanteri CA; Scher AI; Byrne C; Rusiecki J; Ewers E; Epsi NJ; Rozman JS; English C; Simons MP; Tribble DR; Agan BK; Burgess TH;
    JAMA Netw Open; 2023 Jan; 6(1):e2251360. PubMed ID: 36652247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated with Severe COVID-19 and Post-Acute COVID-19 Syndrome in a Cohort of People Living with HIV on Antiretroviral Treatment and with Undetectable HIV RNA.
    Mazzitelli M; Trunfio M; Sasset L; Leoni D; Castelli E; Lo Menzo S; Gardin S; Putaggio C; Brundu M; Garzotto P; Cattelan AM
    Viruses; 2022 Feb; 14(3):. PubMed ID: 35336900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections.
    Taquet M; Dercon Q; Harrison PJ
    Brain Behav Immun; 2022 Jul; 103():154-162. PubMed ID: 35447302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study.
    Cohen K; Ren S; Heath K; Dasmariñas MC; Jubilo KG; Guo Y; Lipsitch M; Daugherty SE
    BMJ; 2022 Feb; 376():e068414. PubMed ID: 35140117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection.
    Brunvoll SH; Nygaard AB; Fagerland MW; Holland P; Ellingjord-Dale M; Dahl JA; Søraas A
    Int J Infect Dis; 2023 Jan; 126():10-13. PubMed ID: 36375693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021.
    Wanga V; Chevinsky JR; Dimitrov LV; Gerdes ME; Whitfield GP; Bonacci RA; Nji MAM; Hernandez-Romieu AC; Rogers-Brown JS; McLeod T; Rushmore J; Lutfy C; Bushman D; Koumans E; Saydah S; Goodman AB; Coleman King SM; Jackson BR; Cope JR
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1235-1241. PubMed ID: 34499626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis.
    Watanabe A; Iwagami M; Yasuhara J; Takagi H; Kuno T
    Vaccine; 2023 Mar; 41(11):1783-1790. PubMed ID: 36774332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients.
    Peghin M; De Martino M; Palese A; Gerussi V; Bontempo G; Graziano E; Visintini E; D'Elia D; Dellai F; Marrella F; Fabris M; Curcio F; Sartor A; Isola M; Tascini C
    Clin Microbiol Infect; 2022 Aug; 28(8):1140-1148. PubMed ID: 35339673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study.
    Augustin M; Stecher M; Wüstenberg H; Di Cristanziano V; Sandaradura de Silva U; Picard LK; Pracht E; Rauschning D; Gruell H; Klein F; Wenisch C; Hallek M; Schommers P; Lehmann C
    Front Immunol; 2023; 14():1226622. PubMed ID: 37781408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection.
    Antar AAR; Yu T; Demko ZO; Hu C; Tornheim JA; Blair PW; Thomas DL; Manabe YC
    Front Immunol; 2023; 14():1147549. PubMed ID: 37187756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms of SARS-CoV-2 infection and vaccine status of sixty-seven adult patients affected by inherited metabolic diseases: a phone survey.
    Brodosi L; Stecchi M; Mita D; Marchignoli F; Guarneri V; Agnelli G; Osti V; Perazza F; Sacilotto F; Pession A; Pironi L
    Orphanet J Rare Dis; 2023 Sep; 18(1):286. PubMed ID: 37700355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences.
    Rahmati M; Udeh R; Yon DK; Lee SW; Dolja-Gore X; McEVoy M; Kenna T; Jacob L; López Sánchez GF; Koyanagi A; Shin JI; Smith L
    J Med Virol; 2023 Jun; 95(6):e28852. PubMed ID: 37288652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived Cognitive Deficits in Patients With Symptomatic SARS-CoV-2 and Their Association With Post-COVID-19 Condition.
    Liu TC; Yoo SM; Sim MS; Motwani Y; Viswanathan N; Wenger NS
    JAMA Netw Open; 2023 May; 6(5):e2311974. PubMed ID: 37145596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological post-acute sequelae of SARS-CoV-2 infection.
    Takao M; Ohira M
    Psychiatry Clin Neurosci; 2023 Feb; 77(2):72-83. PubMed ID: 36148558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal evaluation of neurologic-post acute sequelae SARS-CoV-2 infection symptoms.
    Shanley JE; Valenciano AF; Timmons G; Miner AE; Kakarla V; Rempe T; Yang JH; Gooding A; Norman MA; Banks SJ; Ritter ML; Ellis RJ; Horton L; Graves JS
    Ann Clin Transl Neurol; 2022 Jul; 9(7):995-1010. PubMed ID: 35702954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and determinants of post-acute sequelae of COVID-19 in Liberia.
    Gwaikolo C; Sackie-Wapoe Y; Badio M; Glidden DV; Lindan C; Martin J
    Int J Epidemiol; 2024 Feb; 53(1):. PubMed ID: 38052015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infectionImmunity and inflammaion in post-acute sequelae of SARS-CoV-2 infection.
    Newell KL; Waickman AT
    Curr Opin Immunol; 2022 Aug; 77():102228. PubMed ID: 35724449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom monitoring after coronavirus disease 2019 (COVID-19) vaccination in a large integrated healthcare system: Separating symptoms from severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection.
    Shenoy ES; Wickner PG; West LR; Banerji A; Blumenthal KG; Centi AJ; Gottlieb A; Hashimoto DM; Kim E; Kim M; Lee H; Simpson LA; Landman AB
    Infect Control Hosp Epidemiol; 2022 Oct; 43(10):1439-1446. PubMed ID: 34726142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.